搜索优化
English
搜索
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
时间不限
过去 1 小时
过去 24 小时
过去 7 天
过去 30 天
按相关度排序
按时间排序
Arab Times
23 小时
Diabetes is a leading cause of chronic diseases worldwide
Minister of Health Dr. Ahmad Al-Awadhi stated that diabetes is one of the most prevalent and significant chronic diseases in ...
Rolling Out
6 天
How semaglutide is transforming kidney disease treatment
Semaglutide is revolutionizing kidney disease treatment for type 2 diabetes patients. Learn how it works and its potential ...
8 天
on MSN
This disease is known as the ‘silent killer.’ A doctor explains why
People often let chronic conditions such as high blood pressure and diabetes go for a long time without treatment. Here’s why ...
Ärzteblatt
2 天
The management of chronic kidney disease not requiring renal replacement therapy in general ...
For technical reasons, the English full text will be published approximately two weeks after the German print edition has been published.
Verywell Health on MSN
11 天
What Are the Different Types of Diabetes?
Diabetes mellitus, more commonly known as diabetes, actually consists of many different types. Learn more about the ...
Medscape
3 天
GPs Face Challenges in Chronic Kidney Disease Screening
GPs struggle to integrate albuminuria screening for chronic kidney disease due to confusion over prescribing and interpreting ...
3 天
on MSN
Massive study looks at benefits, risks of GLP-1 weight-loss drugs
As demand for weight-loss injections sold under brand names such as Ozempic and Wegovy continues to soar, a study has ...
Healio
12 天
Obesity medications can tackle metabolic cardiorenal disease
The effects of SGLT2 inhibitors on the kidney to prevent progression of chronic kidney disease, congestive heart failure, ...
Daily Monitor
3 天
Kidney patients trapped in fights over transplants
Patients caught up in the web of delays are struggling with the perils of kidney disease and prohibitive costs of life-saving ...
The Lancet
12 天
Halving heart failure outcomes by finerenone-mediated type 2 diabetes prevention
Type 2 diabetes is common; it affects one in ten adults internationally and one in five adults aged 65 years or older. It is ...
当前正在显示可能无法访问的结果。
隐藏无法访问的结果
反馈